Research powers progress against cancer by increasing our
understanding of the collection of diseases we call cancer
and by allowing us to translate this knowledge into new and
increasingly precise ways to prevent, detect, diagnose, treat,
and cure some of these diseases.
Much of the research that powers progress against cancer
is funded by the U.S. federal government through the
National Institutes of Health (NIH), in particular its largest
component institute, the National Cancer Institute (NCI).
Additionally, federal funding of the U.S. Food and Drug
Administration (FDA) helps speed the delivery of safe and
effective treatments, such as anticancer therapeutics, to the
patients who need them.
As the oldest and largest cancer organization in the world
dedicated to advancing every aspect of cancer research,
from basic science to translational research to clinical
research and population science, the American Association
for Cancer Research (AACR) is committed to increasing
public understanding of cancer and the importance of
cancer research to public health, as well as to advocating
for increased federal funding for the NIH, NCI, and FDA.
These investments will contribute markedly to the goal of
saving more lives from cancer.
The annual AACR Cancer Progress Report to Congress
and the American public is a cornerstone of the AACR’s
educational and advocacy efforts. This fifth edition of the
report chronicles how research continues to transform lives,
like the lives of the 13 courageous individuals featured in
the report who have shared their experiences with cancer.
It also contains a special section showcasing the advances
made against cancer in the five years of publishing the
report. The progress against cancer highlighted in the report
underscores how unwavering, bipartisan support from
Congress and the administration, in the form of sustained
increases in funding for the NIH, NCI, and FDA, are vital
if we are to continue to make progress for the benefit of
Cancer in 2015
Research is the foundation of new and better approaches
to cancer prevention, detection, diagnosis, and treatment,
which are driving down overall U.S. cancer death rates and
increasing the number of people who are living longer,
higher-quality lives after a cancer diagnosis.
since i started
working in the
field of oncology
decades ago, there
has been a sea
change in our basic
what cancer is … ”
aacr Presiden T, 2015–2016, José baseLga, md, Phd
Even though extraordinary advances have been made,
cancer continues to exert an enormous global toll. In
2015 alone, it is estimated that about 8. 9 million people
worldwide will die from some form of cancer, 589,430 of
whom are individuals living in the United States. Moreover,
these numbers are projected to increase dramatically in the
coming decades if new and better ways to prevent, detect,
diagnose, and treat cancer are not developed.
Fueling the anticipated increase in cancer deaths will be a
rise in the number of cancer diagnoses, which will, in turn,
drive up the costs of cancer. In the United States alone, it
is estimated that the direct medical costs of cancer care
will rise to $156 billion in 2020, from nearly $125 billion
in 2010. When these costs are compared to the total NCI
budget for fiscal year 2015, which is just $5 billion, it is clear
that research that spurs lifesaving progress against cancer is
a wise national investment.
14. 5 million
people with a history of cancer
were estimated to be alive in the
united states on Jan. 1, 2014.